NorthRock Partners LLC Makes New $140,000 Investment in UiPath, Inc. $PATH

NorthRock Partners LLC purchased a new position in UiPath, Inc. (NYSE:PATH) during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm purchased 10,941 shares of the company’s stock, valued at approximately $140,000.

Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. GAMMA Investing LLC grew its position in UiPath by 48.0% in the 2nd quarter. GAMMA Investing LLC now owns 2,989 shares of the company’s stock worth $38,000 after purchasing an additional 969 shares during the last quarter. Xponance Inc. grew its position in UiPath by 2.0% in the 1st quarter. Xponance Inc. now owns 54,246 shares of the company’s stock worth $559,000 after purchasing an additional 1,054 shares during the last quarter. Covestor Ltd grew its position in UiPath by 13.1% in the 1st quarter. Covestor Ltd now owns 11,070 shares of the company’s stock worth $114,000 after purchasing an additional 1,283 shares during the last quarter. CX Institutional grew its position in UiPath by 43.3% in the 2nd quarter. CX Institutional now owns 5,014 shares of the company’s stock worth $64,000 after purchasing an additional 1,515 shares during the last quarter. Finally, Cetera Investment Advisers grew its position in UiPath by 2.3% in the 1st quarter. Cetera Investment Advisers now owns 74,696 shares of the company’s stock worth $769,000 after purchasing an additional 1,652 shares during the last quarter. 62.50% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at UiPath

In other UiPath news, CFO Ashim Gupta sold 240,874 shares of the business’s stock in a transaction dated Thursday, October 9th. The shares were sold at an average price of $17.28, for a total value of $4,162,302.72. Following the completion of the transaction, the chief financial officer directly owned 696,117 shares of the company’s stock, valued at approximately $12,028,901.76. The trade was a 25.71% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO Daniel Dines sold 122,734 shares of the business’s stock in a transaction dated Wednesday, October 8th. The stock was sold at an average price of $14.89, for a total transaction of $1,827,509.26. Following the completion of the transaction, the chief executive officer directly owned 613,670 shares of the company’s stock, valued at approximately $9,137,546.30. This represents a 16.67% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 2,178,990 shares of company stock worth $31,056,331. Company insiders own 23.19% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have recently weighed in on PATH. Zacks Research upgraded shares of UiPath from a “hold” rating to a “strong-buy” rating in a research report on Monday, September 8th. DA Davidson began coverage on shares of UiPath in a research report on Friday, September 5th. They set a “neutral” rating and a $12.00 target price on the stock. Wall Street Zen upgraded shares of UiPath from a “buy” rating to a “strong-buy” rating in a research report on Saturday, September 6th. Canaccord Genuity Group decreased their target price on shares of UiPath from $16.00 to $15.00 and set a “buy” rating on the stock in a research report on Monday, September 8th. Finally, Weiss Ratings reiterated a “sell (d)” rating on shares of UiPath in a research report on Wednesday, October 8th. One investment analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, twelve have assigned a Hold rating and three have given a Sell rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $13.21.

UiPath Stock Down 3.1%

NYSE:PATH opened at $15.44 on Friday. The firm has a market cap of $8.20 billion, a PE ratio of 514.77, a price-to-earnings-growth ratio of 5.89 and a beta of 1.07. UiPath, Inc. has a 12 month low of $9.38 and a 12 month high of $18.74. The company’s 50-day moving average price is $12.52 and its two-hundred day moving average price is $12.22.

UiPath (NYSE:PATH) last released its quarterly earnings results on Thursday, September 4th. The company reported $0.15 EPS for the quarter, beating analysts’ consensus estimates of $0.08 by $0.07. The firm had revenue of $361.73 million for the quarter, compared to analyst estimates of $347.36 million. UiPath had a net margin of 1.35% and a return on equity of 1.28%. The company’s revenue for the quarter was up 14.6% compared to the same quarter last year. During the same period in the previous year, the business earned $0.04 earnings per share. UiPath has set its FY 2026 guidance at EPS. Q3 2026 guidance at EPS. On average, research analysts expect that UiPath, Inc. will post -0.17 EPS for the current fiscal year.

About UiPath

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.